// App-Quantinova.ai

e21680 : Epoetin zeta in patients with hematological malignancies with or without iron supplementation: A sub-analysis of the SYNERGY study.

Researchers

Presenter

  • Isabelle Laure Ray-Coquard

Principal Investigators

  • Kamel Laribi

  • Christian Gisselbrecht

  • Dominique Spaeth

  • Emna Kasdaghli

  • Florian Scotte

Medical Centers

  • Centre Leon Berard, Lyon, France

  • Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France

  • Hospital Saint Antoine, Paris, France

  • ORACLE, Centre d'Oncologie de Gentilly, Gentilly, France

  • Hospira France, Meudon La foret, France

  • Hopital European Georges Pompidou, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Epo-zeta

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • NCT02158169

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved